Overview
Karo Healthcare develops and markets branded medicines and personal care products for everyday health needs, including skin care, foot treatments and supplements. Its portfolio combines pharmacy brands such as E45 and Lamisil with wellness products sold under Nutravita. The business earns revenue from sales of its own brands through pharmacies, retailers, online stores and healthcare distributors, while its teams manage product development and commercial execution across markets. Its medicines include over-the-counter and prescription products, alongside cosmetics and other consumer health products. Founded in 1987, Karo Healthcare is headquartered in Stockholm, Sweden.
Work here?Claim your company
Simplify's Take
What believers are saying
- April 2026 added ACO, Biodermal, Emolium and Iwostin to Karo through its completed purchase from Perrigo.
- Karo's Everything Counts Programme links employee financial rewards to company success.
- June 2026 expanded Karo's nail fungus licensing partnership into China's cross-border ecommerce channel.
What critics are saying
- March 2026 approval of Karo's ACO purchase required divesting Nordic Locobase rights, limiting the brands retained after consolidation.
- Karo depends on contract manufacturers and third-party logistics providers, placing production and distribution execution with external partners.
- Karo's Warsaw Emolium brand manager role lasts 18 months as parental leave cover.
What makes Karo Healthcare unique
- Karo organises cross-functional squads around individual brands or categories, putting decisions with the teams managing them.
- Karo runs Amazon and direct consumer marketing with its own account, performance marketing and creative production teams.
- Selected Karo medicines carry Sweden's Välvald pharmacy label, requiring manufacturing-site disclosure and responsible sourcing controls.
Help us improve and share your feedback! Did you find this helpful?